MACH7 TECHNOLOGIES LIMITED — Director's Dealing 2015

Dec 23, 2015

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity 3D Medical Limited ABN 26 007 817 192

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Nigel Finch
Date of last notice	7 December 2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

	Direct or indirect interest			Direct interest
	Nature of indirect interest			N/A
	(including registereNote: Provide details of threlevant interest	d holder)e circumstances gi	ving rise to the
	.
	Date of change				24 December 2015
	No. of securities he	ld prior to ch	ange		•1,884,317 ordinary shby Dr Nigel Finch anJane Finch•711,659 options exerc	ares held joind Mrs Elizabisable at $0.	tlyeth0505
					each on or before 06/•424,257 options exerceach on or before 06/0	8/2016isable at $0.2/2017
	Class				Ordinary shares
	Number acquired				200,000 ordinary shares
	Number disposed				Nil
	Value/ConsideratioNote: If consideration is non	n-cash provide detai	ls and estimated		$0.075 per share
+ See chapter 19 for defin valuation	valuation	,
		ed terms

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	•2,084,317 ordinary shares held jointly
	by Dr Nigel Finch and Mrs Elizabeth
	Jane Finch
	•711,659 options exercisable at $0.05
	each on or before 06/08/2016
	•424,257 options exercisable at $0.05
	each on or before 06/02/2017
Nature of change	Participation in Share Purchase Plan
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation
in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to	N/A
which interest related prior to
change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change	N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contractsdetailed above traded during a+closed periodwhereprior written clearance was required?	No
If so, was prior written clearance provided to allowthe trade to proceed during this period?	N/A
If prior written clearance was provided, on whatdate was this provided?	N/A

See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011